These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
529 related articles for article (PubMed ID: 8207420)
1. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors. Wachtel SR; Abercrombie ED J Neurochem; 1994 Jul; 63(1):108-17. PubMed ID: 8207420 [TBL] [Abstract][Full Text] [Related]
2. Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats. Finberg JP; Wang J; Goldstein DS; Kopin IJ; Bankiewicz KS J Neurochem; 1995 Sep; 65(3):1213-20. PubMed ID: 7643100 [TBL] [Abstract][Full Text] [Related]
3. In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolism. Brannan T; Prikhojan A; Martínez-Tica J; Yahr MD J Neural Transm Park Dis Dement Sect; 1995; 10(2-3):79-89. PubMed ID: 9620056 [TBL] [Abstract][Full Text] [Related]
4. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys. Di Monte DA; DeLanney LE; Irwin I; Royland JE; Chan P; Jakowec MW; Langston JW Brain Res; 1996 Oct; 738(1):53-9. PubMed ID: 8949927 [TBL] [Abstract][Full Text] [Related]
5. Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats. Miller DW; Abercrombie ED J Neurochem; 1999 Apr; 72(4):1516-22. PubMed ID: 10098856 [TBL] [Abstract][Full Text] [Related]
6. Increased L-DOPA-derived dopamine following selective MAO-A or -B inhibition in rat striatum depleted of dopaminergic and serotonergic innervation. Sader-Mazbar O; Loboda Y; Rabey MJ; Finberg JP Br J Pharmacol; 2013 Nov; 170(5):999-1013. PubMed ID: 23992249 [TBL] [Abstract][Full Text] [Related]
7. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain. Nguyen TB; Angers M Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430 [TBL] [Abstract][Full Text] [Related]
8. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo. Lamensdorf I; Youdim MB; Finberg JP J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937 [TBL] [Abstract][Full Text] [Related]
10. Effects of subchronic treatment with selegiline on L-DOPA-induced increase in extracellular dopamine level in rat striatum. Adachi K; Miwa H; Kusumoto H; Shimazu S; Kondo T J Pharmacol Sci; 2006 Aug; 101(4):286-92. PubMed ID: 16891770 [TBL] [Abstract][Full Text] [Related]
11. Influence of monoamine oxidase inhibitors on striatonigral dynorphin system: a study with deprenyl and clorgyline. Sivam SP Neuropeptides; 1993 Jul; 25(1):35-45. PubMed ID: 7692341 [TBL] [Abstract][Full Text] [Related]
12. Effect of a selective MAO-A inhibitor (Ro 41-1049) on striatal L-dopa and dopamine metabolism: an in vivo study. Brannan T; Prikhojan A; Yahr MD J Neural Transm Park Dis Dement Sect; 1994; 8(1-2):99-105. PubMed ID: 7893380 [TBL] [Abstract][Full Text] [Related]
13. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine. Jackson D; Abercrombie ED; Zigmond MJ J Pharmacol Exp Ther; 1993 Nov; 267(2):912-8. PubMed ID: 8246167 [TBL] [Abstract][Full Text] [Related]
14. Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl. Hársing LG; Vizi ES Br J Pharmacol; 1984 Nov; 83(3):741-9. PubMed ID: 6439273 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum. Paterson IA; Juorio AV; Berry MD; Zhu MY J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846 [TBL] [Abstract][Full Text] [Related]
16. Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Abercrombie ED; Bonatz AE; Zigmond MJ Brain Res; 1990 Aug; 525(1):36-44. PubMed ID: 2123121 [TBL] [Abstract][Full Text] [Related]
17. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile. Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694 [TBL] [Abstract][Full Text] [Related]
18. Preferential deamination of dopamine by an A type monoamine oxidase in rat brain. Waldmeier PC; Delini-Stula A; Maître L Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):9-14. PubMed ID: 934359 [TBL] [Abstract][Full Text] [Related]
19. L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats. Xu K; Dluzen DE J Neural Transm (Vienna); 1996; 103(11):1295-305. PubMed ID: 9013416 [TBL] [Abstract][Full Text] [Related]
20. Striatal L-dopa metabolism studied in vivo in rats with nigrostriatal lesions. Brannan T; Bhardwaj A; Martinez-Tica J; Weinberger J; Yahr M J Neural Transm Park Dis Dement Sect; 1990; 2(1):15-22. PubMed ID: 2113388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]